{"disease":{"id":"inflamatory-bowel-disease","name":"inflamatory bowel disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07181525","title":"Construction and Validation of a Predictive Model for the Efficacy of Different Biologics in Inflammatory Bowel Disease","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT07184138","title":"Real-World Study on the Safety and Effectiveness of IL-23 Inhibitors for Inflammatory Bowel Disease in China","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":178,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT07484620","title":"Physical Activity and Fitness in Pediatric Inflammatory Bowel Disease","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Universidad Complutense de Madrid","has_results":false},{"nct_id":"NCT07487311","title":"A Prospective Cohort Study Evaluating the Efficacy and Safety of Guselkumab (GUS) With JAK Inhibitors in Patients With Difficult-To-Treat Inflammatory Bowel Disease (IBD)","phase":"","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT07347158","title":"Effectiveness of Health Education as a Nursing Intervention in Improving Quality of Life and Reducing Symptoms of Anxiety and Depression in Ostomy Patients Following Digestive Surgery: A Quasi-Experimental Study.","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":70,"lead_sponsor_name":"Hospital Clinico Universitario de Santiago","has_results":false},{"nct_id":"NCT07487480","title":"A Prospective Observational Study on the Efficacy and Safety of Guselkumab in the Treatment of Crohn's Disease Patients Previously Treated With Ustekinumab","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT07273188","title":"68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT07416383","title":"Safety and Efficiency of the Universal CNK-UT009 in Difficult-to-treat Inflammatory Bowel Disease Patients","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT06867939","title":"A Study of Curcumin (Soloways ™) in Patients With Inflammatory Bowel Disease Homozygous for the IL-10 Variant","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"S.LAB (SOLOWAYS)","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}